HERSHBERG ROBERT (CIK 1274139) reported 9 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-22). Recent activity: Buy RXRX (88,424 shares), Buy ADPT (15,625 shares), Sell ADPT (22,968 shares), Sell HLVX (1.1M shares), Buy RXRX (22,016 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 88,424 | $0 |
| 2026-03-06 | Adaptive Biotechnologies Corp (ADPT) | Director | Buy | 15,625 | $0 |
| 2025-12-12 | Adaptive Biotechnologies Corp (ADPT) | Director | Sell | 22,968 | $367,488 |
| 2025-09-17 | HilleVax, Inc. (HLVX) | President and CEO | Sell | 1.1M | $0 |
| 2025-06-23 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | Buy | 22,016 | $0 |
| 2025-03-12 | Adaptive Biotechnologies Corp (ADPT) | Director | Sell | 53,000 | $402,270 |
| 2025-03-06 | Adaptive Biotechnologies Corp (ADPT) | Director | Buy | 15,394 | $0 |
| 2025-02-12 | HilleVax, Inc. (HLVX) | See Remarks | Sell | 14,634 | $27,658 |
| 2025-02-12 | HilleVax, Inc. (HLVX) | See Remarks | Sell | 11,901 | $20,946 |
Source: SEC Form 4 filings · as of 2026-06-22